Greifswald, Germany

Michael Hecker

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Basf Se Corporation. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Hecker: Innovator in Fermentation Technology

Introduction

Michael Hecker is a notable inventor based in Greifswald, Germany. He has made significant contributions to the field of fermentation technology, particularly through his innovative approaches to microorganisms and their applications.

Latest Patents

Hecker holds a patent for "Enhanced Fermentation." This invention relates to fermentation technology and microorganisms that are useful for such processes. It encompasses materials, including nucleic acids and proteins, that can alter the fermentation characteristics of microorganisms. Specifically, the invention focuses on materials that can confer, modify, or reduce microbial stress resistance.

Career Highlights

Throughout his career, Michael Hecker has worked with prominent organizations such as BASF SE Corporation and Universitätsmedizin Greifswald Körperschaft Des Öffentlichen Rechts Institut Für Immunologie Und Transfusionsmedizin Abteilung Immunologie. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

He has collaborated with notable colleagues, including Max Fabian Felle and Stefan Jenewein. These partnerships have further enriched his research and innovation in the field.

Conclusion

Michael Hecker's contributions to fermentation technology and his innovative patent demonstrate his commitment to advancing scientific knowledge. His work continues to influence the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…